Neuraptive Therapeutics Inc. Report issue

For profit Phase 2
Founded: Lafayette CO United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04572906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Neuraptive Therapeutics Inc.